{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:08:27Z","timestamp":1787998107029,"version":"build-2784847793"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T00:00:00Z","timestamp":1478476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u00d6resund Diabetes Academy"},{"DOI":"10.13039\/501100000273","name":"Diabetes Research & Wellness Foundation","doi-asserted-by":"publisher","award":["SCA\/01\/F\/07"],"award-info":[{"award-number":["SCA\/01\/F\/07"]}],"id":[{"id":"10.13039\/501100000273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0165668","type":"journal-article","created":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T18:33:28Z","timestamp":1478543608000},"page":"e0165668","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Metformin Ameliorates Dysfunctional Traits of Glibenclamide- and Glucose-Induced Insulin Secretion by Suppression of Imposed Overactivity of the Islet Nitric Oxide Synthase-NO System"],"prefix":"10.1371","volume":"11","author":[{"given":"Ingmar","family":"Lundquist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israa","family":"Mohammed Al-Amily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Meidute Abaraviciene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6120-3539","authenticated-orcid":true,"given":"Albert","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"SE Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"SE Kahn","year":"2014","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2337\/diabetes.49.5.735","article-title":"Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells","volume":"49","author":"G Patane","year":"2000","journal-title":"Diabetes"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1210\/jc.2004-0150","article-title":"Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin","volume":"89","author":"P Marchetti","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"SE Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1677\/joe.0.1630039","article-title":"Islet constitutive nitric oxide synthase and glucose regulation of insulin release in mice","volume":"163","author":"B Akesson","year":"1999","journal-title":"J Endocrinol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"C296","DOI":"10.1152\/ajpcell.00537.2001","article-title":"Role of nitric oxide synthase isoforms in glucose-stimulated insulin release","volume":"283","author":"R Henningsson","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00018-008-8100-8","article-title":"Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities","volume":"65","author":"SM Abaraviciene","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1463-1326.2012.01632.x","article-title":"Pancreatic beta-cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes","volume":"14","author":"SJ Muhammed","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s001250051256","article-title":"Morphological evidence for the existence of nitric oxide and carbon monoxide pathways in the rat islets of Langerhans: an immunocytochemical and confocal microscopical study","volume":"42","author":"P Alm","year":"1999","journal-title":"Diabetologia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2337\/diabetes.50.6.1311","article-title":"A neuronal isoform of nitric oxide synthase expressed in pancreatic beta-cells controls insulin secretion","volume":"50","author":"AD Lajoix","year":"2001","journal-title":"Diabetes"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s00125-011-2264-8","article-title":"Increased neuronal nitric oxide synthase dimerisation is involved in rat and human pancreatic beta cell hyperactivity in obesity","volume":"54","author":"K Mezghenna","year":"2011","journal-title":"Diabetologia"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1073\/pnas.90.5.1731","article-title":"Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans","volume":"90","author":"JA Corbett","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/BF00403906","article-title":"The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells","volume":"39","author":"DL Eizirik","year":"1996","journal-title":"Diabetologia"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"RA Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00441-004-1013-4","article-title":"Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP\/PKA pathway","volume":"319","author":"J Jimenez-Feltstrom","year":"2005","journal-title":"Cell Tissue Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"E95","DOI":"10.1152\/ajpendo.2000.279.1.E95","article-title":"Chronic blockade of NO synthase paradoxically increases islet NO production and modulates islet hormone release","volume":"279","author":"R Henningsson","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e2165","DOI":"10.1371\/journal.pone.0002165","article-title":"Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1","volume":"3","author":"A Salehi","year":"2008","journal-title":"PLoS ONE"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.regpep.2008.07.002","article-title":"Impaired glucose-stimulated insulin secretion in the GK rat is associated with abnormalities in islet nitric oxide production","volume":"151","author":"H Mosen","year":"2008","journal-title":"Regul Pept"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/diabetes.48.6.1230","article-title":"Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose","volume":"48","author":"S Marshak","year":"1999","journal-title":"Diabetes"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11154-008-9101-5","article-title":"Beta-cell failure as a complication of diabetes","volume":"9","author":"KJ Chang-Chen","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1172\/JCI119534","article-title":"Role of nitric oxide in obesity-induced beta cell disease","volume":"100","author":"M Shimabukuro","year":"1997","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/ENDO:16:2:097","article-title":"Total parenteral nutrition modulates hormone release by stimulating expression and activity of inducible nitric oxide synthase in rat pancreatic islets","volume":"16","author":"A Salehi","year":"2001","journal-title":"Endocrine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00007890-198510000-00018","article-title":"An improved method for isolation of mouse pancreatic islets","volume":"40","author":"M Gotoh","year":"1985","journal-title":"Transplantation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"C1634","DOI":"10.1152\/ajpcell.1996.270.6.C1634","article-title":"Islet constitutive nitric oxide synthase: biochemical determination and regulatory function","volume":"270","author":"A Salehi","year":"1996","journal-title":"Am J Physiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"MM Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"C1242","DOI":"10.1152\/ajpcell.2001.280.5.C1242","article-title":"Evaluation of islet heme oxygenase-CO and nitric oxide synthase-NO pathways during acute endotoxemia","volume":"280","author":"R Henningsson","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref28","first-page":"91","article-title":"Modulation of the islet nitric oxide system and sulphonylurea-induced insulin secretion","volume":"31","author":"B \u00c5kesson","year":"1996","journal-title":"Diabetes Research"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1074\/jbc.273.5.2493","article-title":"Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis","volume":"273","author":"T Takamura","year":"1998","journal-title":"Journal of Biological Chemistry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.regpep.2011.04.011","article-title":"Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob\/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes","volume":"170","author":"J Jimenez-Feltstrom","year":"2011","journal-title":"Regul Pept"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"ra94","DOI":"10.1126\/scisignal.2004581","article-title":"Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A","volume":"6","author":"T Takahashi","year":"2013","journal-title":"Sci Signal"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/bbrc.1998.9601","article-title":"Endogenous nitric oxide inhibits glucose-induced insulin secretion by suppression of phosphofructokinase activity in pancreatic islets","volume":"252","author":"Y Tsuura","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00424-010-0862-9","article-title":"Oxidative stress and beta-cell dysfunction","volume":"460","author":"G Drews","year":"2010","journal-title":"Pflugers Arch"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrm1569","article-title":"Protein S-nitrosylation: purview and parameters","volume":"6","author":"DT Hess","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/157339912800840514","article-title":"The good and bad effects of cysteine S-nitrosylation and tyrosine nitration upon insulin exocytosis: a balancing act","volume":"8","author":"DA Wiseman","year":"2012","journal-title":"Curr Diabetes Rev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.abb.2009.01.021","article-title":"Glucose-modulated tyrosine nitration in beta cells: targets and consequences","volume":"484","author":"T Koeck","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35055104","article-title":"Protein S-nitrosylation: a physiological signal for neuronal nitric oxide","volume":"3","author":"SR Jaffrey","year":"2001","journal-title":"Nat Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mce.2012.06.020","article-title":"Role of AMPK in pancreatic beta cell function","volume":"366","author":"A Fu","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2013.12.031","article-title":"Prevention by metformin of alterations induced by chronic exposure to high glucose in human islet beta cells is associated with preserved ATP\/ADP ratio","volume":"104","author":"M Masini","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","article-title":"Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-alpha in mice","volume":"54","author":"A Maida","year":"2011","journal-title":"Diabetologia"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00125-010-1986-3","article-title":"New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser","volume":"54","author":"YM Cho","year":"2011","journal-title":"Diabetologia"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/dc15-0488","article-title":"The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies","volume":"39","author":"JB Buse","year":"2016","journal-title":"Diabetes Care"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"f1263","DOI":"10.1136\/bmj.f1263","article-title":"GLP-1 based agents and acute pancreatitis: drug safety falls victim to the three monkey paradigm","volume":"346","author":"EA Gale","year":"2013","journal-title":"BMJ"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2337\/dc12-2713","article-title":"A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?","volume":"36","author":"PC Butler","year":"2013","journal-title":"Diabetes Care"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/db15-0122","article-title":"Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB","volume":"65","author":"LM Berglund","year":"2016","journal-title":"Diabetes"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11595370-000000000-00000","article-title":"Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrants","volume":"32","author":"JJ Holst","year":"2012","journal-title":"Clin Drug Investig"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1385\/ENDO:11:1:99","article-title":"Nitric oxide and hydroperoxide affect islet hormone release and Ca(2+) efflux","volume":"11","author":"B Akesson","year":"1999","journal-title":"Endocrine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0165668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T17:30:53Z","timestamp":1657647053000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0165668"}},"subtitle":[],"editor":[{"given":"Claudia","family":"Miele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,7]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0165668","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,7]]}}}